Literature DB >> 19711235

Cross-language generalization following treatment in bilingual speakers with aphasia: a review.

Kathryn Kohnert1.   

Abstract

The focus of this article is on the potential transfer or generalization of positive effects from a treated to an untreated language in bilingual or multilingual individuals with primary acquired aphasia. Twelve studies are reviewed: All were previously published in English in peer-reviewed journals. Half of these studies failed to account for spontaneous recovery. Results from the remaining case reports and single-subject studies are mixed, with four finding evidence for cross-language generalization under some conditions and two finding that improved language performance was restricted to the treated language. Collective findings are discussed within the broader literature in terms of factors to consider when planning for effective, efficient intervention with bilinguals with aphasia.

Entities:  

Mesh:

Year:  2009        PMID: 19711235     DOI: 10.1055/s-0029-1225954

Source DB:  PubMed          Journal:  Semin Speech Lang        ISSN: 0734-0478            Impact factor:   1.761


  10 in total

1.  Video-Implemented Script Training in a Bilingual Spanish-English Speaker With Aphasia.

Authors:  Stephanie M Grasso; Diana F Cruz; Rosa Benavidez; Elizabeth D Peña; Maya L Henry
Journal:  J Speech Lang Hear Res       Date:  2019-06-27       Impact factor: 2.297

2.  Prophylactic Treatments for Anomia in the Logopenic Variant of Primary Progressive Aphasia: Cross-Language Transfer.

Authors:  Aaron M Meyer; Sarah F Snider; Carol B Eckmann; Rhonda B Friedman
Journal:  Aphasiology       Date:  2015       Impact factor: 2.773

3.  Parallel recovery in a trilingual speaker: the use of the Bilingual Aphasia Test as a diagnostic complement to the Comprehensive Aphasia Test.

Authors:  David W Green; Louise Ruffle; Alice Grogan; Nilufa Ali; Sue Ramsden; Tom Schofield; Alex P Leff; Jenny Crinion; Cathy J Price
Journal:  Clin Linguist Phon       Date:  2011-03-31       Impact factor: 1.346

4.  Predicting language treatment response in bilingual aphasia using neural network-based patient models.

Authors:  Uli Grasemann; Claudia Peñaloza; Maria Dekhtyar; Risto Miikkulainen; Swathi Kiran
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

5.  Effect of Mandarin Verb Network Strengthening Treatment (VNeST) in Mandarin-English bilinguals with aphasia: A single-case experimental design.

Authors:  Ran Li; Wen Li; Swathi Kiran
Journal:  Neuropsychol Rehabil       Date:  2020-06-05       Impact factor: 2.928

6.  Treatment for Anomia in Bilingual Speakers with Progressive Aphasia.

Authors:  Stephanie M Grasso; Elizabeth D Peña; Nina Kazemi; Haideh Mirzapour; Rozen Neupane; Borna Bonakdarpour; Maria Luisa Gorno-Tempini; Maya L Henry
Journal:  Brain Sci       Date:  2021-10-20

7.  Telerehabilitation for Word Retrieval Deficits in Bilinguals With Aphasia: Effectiveness and Reliability as Compared to In-person Language Therapy.

Authors:  Claudia Peñaloza; Michael Scimeca; Angelica Gaona; Erin Carpenter; Nishaat Mukadam; Teresa Gray; Shilpa Shamapant; Swathi Kiran
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

Review 8.  Aphasia therapy in the age of globalization: cross-linguistic therapy effects in bilingual aphasia.

Authors:  Ana Inés Ansaldo; Ladan Ghazi Saidi
Journal:  Behav Neurol       Date:  2014-03-11       Impact factor: 3.342

9.  What can speech production errors tell us about cross-linguistic processing in bilingual aphasia? Evidence from four English/Afrikaans bilingual individuals with aphasia.

Authors:  Diane Kendall; Lisa Edmonds; Anine Van Zyl; Inge Odendaal; Molly Stein; Anita van der Merwe
Journal:  S Afr J Commun Disord       Date:  2015-06-26

10.  Predicting treatment outcomes for bilinguals with aphasia using computational modeling: Study protocol for the PROCoM randomised controlled trial.

Authors:  Claudia Peñaloza; Maria Dekhtyar; Michael Scimeca; Erin Carpenter; Nishaat Mukadam; Swathi Kiran
Journal:  BMJ Open       Date:  2020-11-18       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.